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Available online 9 December 2019Objective: The objective of this study was to perform a cross-cultural adaption and psychometric evaluation of
the Spanish version of the Satisfaction with Epilepsy Care (SEC) questionnaire and analyze patient satisfaction
with epilepsy care.
Methods: Transcultural adaptation and validation of the SEC were carried out using translation and
back-translation with pilot testing and an expert panel. The SEC-E (Spanish) was analyzed in 213 patients
with epilepsy to examine construct and criterion validity and internal consistency.
Results: The SEC-E achieved conceptual, semantic, and content equivalence with the original version. For content
validity, one question was eliminated from the original questionnaire as it has little relevance in our cultural
setting. Positive correlations for criterion validity were obtained using the gold standard measure (Satisfaction
in Hospitalized Patients scale). Construct validity replicated the three dimensions of the original questionnaire.
The scale showed adequate reliability through internal consistency (Cronbach'sα of 0.94) and temporal stability
on retest (n = 85). Patients scored (0 to 100) 77.5 [standard deviation (SD): 19.9] for satisfaction with
communication, 76.9 (SD: 17) for organization, and 67.2 (SD: 22.1) for information.
Significance: The SEC-E is a valid and reliable tool for the assessment of educational interventions aiming to
improve the quality of care in patients with epilepsy in Spanish clinical practice. The results showed a good
level of patient satisfaction with epilepsy care.








Epilepsy is a chronic diseasewith a profound impact on the health and
quality of life of patients and their relatives [1]. Seizures are unpredictable
and sometimes dangerous, increasing the risk of injury, hospitalization,
and mortality. Epilepsy may be associated with psychiatric comorbidity
(e.g., anxiety and depression) and cognitive impairment [2,3]. Antiepilep-
tic drugs are often associatedwith adverse effects thatmay limit patients'
quality of life and, consequently, hinder treatment adherence. As such,
successful management of epilepsy requires a holistic approach focusing
on personalized care, patients' needs, and communication with health
professionals using a multidisciplinary approach [2]., Calle Villarroel 170, CP 08036
. This is an open access article underRecent decades have seen growing interest in the measurement,
assessment, and improvement of quality in healthcare. Assessment
methods are used to evaluate patients' perception of their illness, the in-
fluence of health systems, and the quality of specific education and ad-
vice received. Patient satisfaction is a useful indicator of the quality of
health services [4]. Therefore, valid and reliable tools to measure the
degree of patient satisfaction are essential for the development and
implementation of specific procedures to improve care quality [4].
The evaluation of care quality in people with epilepsy should also
take into account the degree of disease control, the kind of care received,
the quality of communication with health professionals, and the type of
information received by the patient. Advice to patients should include
appropriate information about the disease and also assessment of rele-
vant quality dimensions in holistic care from the user's perspective.
Users and their satisfaction are one of the main axes of health services
from a patient-centered health perspective [4]. Users increasinglythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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health professionals, and more active participation in decision-making
about their care [5]. Thus, assessing patient satisfaction allows evalua-
tion of patients' perception of health procedures, administrative aspects,
and treatments given and may lead to improve treatment adherence
and greater continuity in the use of health services [5].
Empowerment, defined as a complex experience of personal change
guided by the principle of self-determination, has been recently used as
a model of patient-centered care [6]. Empowerment may be facilitated
by healthcare providers when they adopt a patient-centered approach
to increase knowledge about biopsychological, functional, experimen-
tal, ethical, social, and financial aspects [7,8]. However, to empower pa-
tients, professional interventions must be measured from the patient's
perspective, which requires specific satisfaction tools to engage patients
in their own care.
The multidimensional concept of patient satisfaction includes vari-
ous domains such as waiting times for appointments, communication
with professionals, financial aspects, and global satisfaction. In epilepsy,
other aspects such as social support, professional development, and
driving capability must be considered [9]. However, there are few
tools that assess patient satisfaction in epilepsy, with no questionnaires
in Spanish. Some general questionnaires that assess satisfaction are in-
definite, or their psychometric properties have not been studied. The
Satisfactionwith Epilepsy Care (SEC) questionnaire is the only question-
naire currently used to assess satisfaction with care in epilepsy [9]. The
SEC includes the following three dimensions: satisfactionwith informa-
tion and advice, satisfaction with the communication with healthcare
professionals, and satisfaction with the organization of the institution.
The original German version of the SEC questionnaire is valid and reli-
able. Satisfaction with information and counseling improved signifi-
cantly after an educational intervention carried out by a specialist
epilepsy nurse, compared with a control group, demonstrating that
the satisfaction of patients with epilepsy improves according to the
health education received [9,10]. Therefore, our objective was to adapt
and test the psychometric properties of the Spanish version of the
original questionnaire.
2. Material and methods
2.1. Study design
A cross-sectional psychometric studywasdesigned. The principal at-
tributes evaluated were linguistic and cultural adaptation, reliability,
and validity.
2.2. Setting and sample
The study population included patients with epilepsy aged
≥18 years attended by the epilepsy unit of a tertiary hospital in
Barcelona, Spain who agreed to complete the questionnaire. An ex-
clusion criterionwas the inability of patients to answer the question-
naire because of cognitive or psychiatric comorbidities.
2.3. Variables
All participants were provided with the SEC-E questionnaire and a
demographic questionnaire to collect data on the following variables:
age, sex, disease duration, number of concomitant antiepileptic drugs,
seizure frequency, type of epilepsy, educational level, and occupation.
The validated Satisfaction in Hospitalized Patients (SHP) scale [11],
a quick and easy tool to assess patients' perceived satisfaction, was
also administered to demonstrate criterion validity [11].
The acceptance of the SEC at the time of administration and the
response rate to the questionnaire were assessed as parameters of
usability and functionality.2.4. Translation and validation processes
The translation, adaptation, and cross-cultural validation of the
instrument used a conventional methodology previously used in ques-
tionnaire validation processes [12–16] following these recommended
steps [13]:
2.4.1. Phase 1: translation processes
Cultural adaptation was carried out using the translation-back-
translation method and a review by an expert panel, as follows:
Step 1 – The original scale was translated into Spanish to obtain two
versions of the scale [9]. The translated texts were provided by two
independent bilingual and bicultural professional translators
whose native language was Spanish.
Step 2 – The two Spanish versions of the scale were evaluated by a
third independent translator and combined to generate a prelimi-
nary version of the SEC in Spanish. Subsequently, a panel consisting
of the three translators and the research team reviewed the prelim-
inary versions to resolve ambiguities and disagreements.
Step 3 – The preliminary Spanish version of SECwas back-translated
into German by two independent bilingual, bicultural translators
whose native language was German and who had experience in
health terminology and linguistic and cultural aspects of the German
language, producing two independent back-translated versions of
the scale in German.
Step 4 – Both back-translated German versionswere comparedwith
the original version of the SEC in German by a multidisciplinary
committee formed of the research team and all translators involved
in the process. The committee resolved any discrepancies between
the German and Spanish versions with respect to the similarity of
instructions, items, and answers in the writing process, sentence
structure, meaning, and relevance of the text. Only items that
did not preserve the original meaning were retranslated or
back-translated. Discrepancies were also reviewed with the lead
author of the original German scale (M.P.) who participated in the
final translation.
2.4.2. Phase 2: pilot testing and expert panel
2.4.2.1. Pilot testing. A pilot study was made by providing a prefinalized
questionnaire to 34 participants from our epilepsy unit and asking
them about the clarity of the instructions and items.
2.4.2.2. Expert panel. An expert panel formed of specialists in epilepsy
with different backgrounds and expertise in the disease: a psychiatrist,
a neuropsychologist, a psychologist, five neurologists, and two epilepsy
nurses, rated all SEC items with respect to the clarity (confusing
or clear) of the questions and their relevance using a scale from 1 to 4
(1= not relevant, 2 = not able to evaluate the relevance, 3 = relevant
but needs some changes, 4= relevant and concise). The panel also eval-
uated the clarity of each itemusing a dichotomous rating scale (yes/no).
The panel later analyzed the results of the pilot study. Finally, the panel
assessed the questions and the differences between the original ques-
tionnaire, the independent translations, and the adapted final version.
2.4.3. Phase 3: psychometric testing
The SEC-E was sent to patients by email using the Lime Survey com-
puter program [17], an open source application for the administration
of surveys/questionnaires online. Participants received an email that
included information about the study, informed consent, information
to be provided by the patients (demographic and clinical question-
naires), the SEC-E, and the SHP scale [11]. A reminder message was
Table 1
Demographic and clinical characteristics of patients with epilepsy responding to the
Spanish version of the SEC (n = 213).
Variable
Age (years) 40.4 ± 16.4





Gender (female), n (%) 138 (64.8)








Level of education, n (%)
No formal education 25 (11.7)
Primary education 34 (16)
Secondary education 30 (14.1)
Professional training 48 (22.5)






















Epilepsy control, n (%)
Controlled 162 (76.1)
Uncontrolled 51 (23.9)
Values are expressed as mean ± SD.
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the final collection of the questionnaires; a second email containing the
SEC-E was sent to all participants for retesting.
2.5. Statistical analysis
Validation of the instrument consisted of study of the content
validity, construct validity, criteria validity, and reliability (internal
consistency and test–retest stability). An expert panel of ten profes-
sionals evaluated the clarity of the items and the extent to which they
were representative of epilepsy healthcare providers using the content
validity index at the item level (I-CVI). To examine the underlying struc-
ture of the satisfaction in epilepsy care factors, explanatory factor anal-
ysis (EFA) was performed using principal component analysis (PCA)
with varimax rotation. To determine the number of factors in the PCA
solution, only factors with an eigenvalue of ≥1 were retained. A mini-
mum factor loading of 0.4 was used as the criterion for each retained
item and a difference of ≥0.15 between the primary loading and any
secondary loading for an item; items without this difference were
assigned to the named factors with themost theoretical sense. For crite-
rion validity, a correlation analysiswasmade using the Spearman corre-
lation coefficient to study correlations between the SEC-E and the SHP
scale [11]. Correlations between the SEC subscales were also studied,
assuming that the various subscales gather distinct information (with
moderate or low correlation coefficients). The internal consistency of
the itemswas calculated using Cronbach's alpha, which was considered
acceptable if the value was N0.8. The time reliability of each item was
tested between two similar assessments using the intraclass correlation
coefficient (ICC2,1) andwas performed 1–3 weeks between administra-
tions. There were no missing data as the web form did not allow for
blank answers. All analyses were conducted using R v3.5 for Windows
statistical software package.
2.6. Ethical considerations
The study was approved by the Hospital Clinic Ethics Committee
(reference #HCB/#2017/0008). Participants were informed about the
objective of the study and gavewritten informed consent by completing
the questionnaires, with anonymity and confidentiality of the data
maintained at all times.
3. Results
3.1. Patient characteristics
The questionnaire was emailed to 320 patients with epilepsy and
was returned by 213 participants (69.8% response rate). The mean
time to complete the questionnaire was 5.25 min. Patient demographic
and clinical characteristics are shown in Table 1. The mean age was
40.4 years [standard deviation (SD): 16.4], and 64.9% were female.
Most patients had a disease duration of N20 years (50.2%), and 42%
were taking ≥3 antiepileptic drugs. Twenty-three percent of partici-
pants had weekly or daily seizures, and 23.9% classified their epilepsy
as “uncontrolled”.
3.2. Content validity
3.2.1. Pilot testing of prefinal version
Of the 34 patients who participated in the pilot test, all rated
the questions about communication as “clear”, and 91.2% also
qualified questions about the organization as clear. In contrast,
25.6% of the patients did not find the questions about satisfaction
with the information clear, and these were later analyzed by the
expert panel. The instructions were also considered as clear by
94.1% of participants and the response format by 91.2%.3.2.2. Expert panel
After analyzing the results of the pilot test, the response for-
mat was rewritten to clarify the “no need” option, which was
changed to “I don't need it”; moreover, both options of answering
“not received despite need” and “I don't need it” were highlighted
to clarify the options when there was no answer for the level of
satisfaction.
The second section of the SEC-E, satisfaction with organization,
showed a similar degree of validity, except for questions 2.5 and
2.6 regarding the atmosphere in the hospital/clinic and satisfac-
tion with blood drawing techniques as they were considered irrel-
evant by 60% of experts. Consequently, the expert panel discussed
whether those questions were appropriate and decided to main-
tain the item “satisfaction with the environment in the epilepsy
clinic” in the final version as it was relevant from the patient per-
spective. However, the item “satisfaction with blood drawing
techniques” was considered irrelevant and removed from the
questionnaire.
All items were rated N80% for clarity except the item “Self-
support group”, which was rewritten as “Self-support group and
associations”.
Table 3
Principal component analysis followed by varimax rotation (construct validity).




1.1. Time to address questions 0.76
1.2. Consideration of individual needs 0.77
1.3. Incorporation your ideas in
the treatment process
0.73
1.4. Understanding and empathy 0.67
Satisfaction with organization
2.1. Appointment 0.74
2.2. Time waiting in the clinic 0.76
2.3. Staff friendliness and willingness 0.74
2.4. Familiarity of staff 0.48
2.5. Atmosphere in the clinic 0.72
2.7. Management of diagnostic
processes
0.84




3.3. Effects and adverse effects of AED 0.46 0.60
3.4. Seizure management 0.73
3.5. Own contribution to
improving health condition
0.75
3.6. Self-support groups 0.84
3.7. Career opportunities 0.87
3.8. Provision of aid 0.90
3.9. Problems at school or work 0.76
3.10. Social support 0.67
3.11. Dealing with impact of
epilepsy on family and on oneself
0.82
3.12. Driver's license 0.76
In italics, items assigned to the named factors with the most theoretical sense. In bold,
items corresponding to a different domain with respect to the original version of the
Satisfaction with Epilepsy Care questionnaire.
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Table 2 shows the results of the item category frequencies.
More than 50% of patients responded that they were very satisfied
or satisfied with items corresponding to communication and
organization dimensions, with percentages varying between
56.8% and 83.6%. Two patterns were observed with respect to the
information and assessment dimension. The first group of items,
from 3.1. Epilepsy to 3.5. Own contribution to improving health
condition, had a similar distribution to previous dimensions.
However, items from 3.6. Self-support groups to 3.12. Driver's
license had a lower percentage of very satisfied or satisfied answers
because of a high percentage of “I don't need it” answers, indicating
that these were specific items that patients perceived as not needing
advice on.
The questionnaire scores (0 to 100) were 77.5 (SD: 19.9) for
satisfaction with communication, 76.9 (SD: 17) for organization,
and 67.2 (SD: 22.1) for information.
3.4. Construct validity
A good adjustment of the items to the original structure of the
scale was observed, confirming the three dimensions of the scale.
As shown in Table 3, only items 3.2 and 3.3 appeared to correlate
better with the communication dimension rather than with the
information domain. However, we decided to leave these items
within the information domain to maintain coherence with the
original SEC questionnaire.
3.5. Criterion validity
The three domains of the SEC correlated directly with the items of
the SHP scale (Table 4), suggesting the SEC-E questionnaire is accu-
rate in evaluating satisfaction with communication, organization,
and information.
Comparisons between the SHP and SEC-E items showed a mod-
erate–high Spearman correlation (0.47–0.61, p b 0.01), supportingTable 2
Item category frequencies (%).







1.1. Time to address questions 30 38.5 18.3
1.2. Consideration of individual needs 30.5 33.3 19.2
1.3. Including your ideas in the treatment process 25.8 37.1 17.8
1.4. Understanding and empathy 47.4 30.5 9.9
Satisfaction with organization
2.1. Appointment 27.7 38.5 16.9
2.2. Time waiting in the clinic 16.0 40.8 22.1
2.3. Staff's friendliness and willingness 46.5 37.1 9.9
2.4. Familiarity of staff 35.7 37.1 14.6
2.5. Atmosphere in the clinic 34.3 47.9 11.7
2.7. Management of diagnostic processes 25.8 38.5 17.8
Satisfaction with information and counseling/advice
3.1. Epilepsy 29.1 37.6 13.1
3.2. Treatment 28.6 40.4 12.7
3.3. AED effects and adverse effects 22.1 36.2 15.5
3.4. Seizure management 23.0 35.7 15.5
3.5. Own contribution to improving health condition 23.5 33.8 16.4
3.6. Self-support groups 5.2 15.5 4.2
3.7. Career opportunities 12.2 19.2 8.5
3.8. Provision of aid 11.7 17.4 12.2
3.9. Problems at school or work 12.2 18.3 8.0
3.10. Social support 8.0 17.8 8.9
3.11. Dealing with impact of epilepsy on family and
on oneself
11.3 15.5 16.0
3.12. Driver's license 13.6 16.4 8.5similar concepts underlying questions in both measurements
and indicating that the SEC-E measures what it was intended to












6.6 1.9 1.9 2.8
8.5 3.3 2.3 2.8
7.5 1.4 1.9 8.5
6.1 1.4 1.9 2.8
6.6 5.6 3.3 1.4
11.7 5.2 1.9 2.3
3.3 1.9 0 1.4
4.7 2.8 2.3 2.8
3.3 0 0 2.8
10.3 2.8 3.3 1.4
10.3 5.2 2.3 1.9 0.5
9.9 2.8 2.8 1.9 0.9
11.7 8.5 2.8 2.3 0.9
9.9 2.8 2.3 5.2 5.6
12.7 5.2 2.3 3.3 2.8
8.5 4.2 3.3 18.3 40.8
7.5 8.9 4.2 8.0 31.5
7.5 3.8 2.3 6.6 38.5
7.0 5.2 8.9 9.4 31.0
10.3 7.5 5.6 16.9 24.9
13.6 6.6 7.5 16.4 13.1











3.1. Epilepsy 3.2. Treatment 3.3. Effects and side
effects of AED
1. Time your doctor gives you 0.473⁎
2. Solutions your doctor gives you 0.593⁎⁎ 0.610
3. Interest of your doctor in hearing
your explanation of your illness
0.528 0.468 0.601
4. Information about treatment 0.560 0.565
5. The treatment you received 0.493 0.512
6. Staff willingness to help 0.490 0.517
All Spearman Correlation Coefficients were statistically significant with a p-value lower than 0.05.
⁎ Statistically significant Spearman Correlation Coefficients at 0.05 significance level
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3.6.1. Internal consistency
With respect to the degree of internal consistency, Cronbach's α
value was N0.8 for all three SEC dimensions analyzed (total value:
0.94), indicating good global internal consistency for the question-
naire and for each dimension. The three dimensions correlated
with each other (Spearman correlation coefficients: 0.621, 0.687,
and 0.563; p b 0.05).
3.6.2. Retest
The response rate to the SEC-E retest was 39.9% (85 patients). The
temporal stability test showed no relevant changes between the first
and the second questionnaires, with a significant ICC2,1 being obtained
in all items evaluated (p b 0.001), indicating good temporal stability.
4. Discussion
This study translated and validated the SEC questionnaire into
Spanish (SEC-E), providing a useful tool to evaluate satisfaction with
the organization, communication, and information received by patients
with epilepsy and providing a basis for future changes or interventions
that can improve patient care in specific areas.
This is the first study to evaluate satisfaction among patients with ep-
ilepsy in Spain and the Mediterranean. The results showed moderate–
high patient satisfaction with most items, and the global findings were
comparable with the results obtained for the original German scale [9],
except for slightly lower values for satisfaction with organization
(76.9 ± 17 in SEC-E vs. 81.1 in SEC), which might be explained
by differences in the organization of outpatient healthcare. Some
discrepancies between the two questionnaires could be due to the
methodology followed in the SEC-E validation, which was based on
online anonymous surveys, allowing higher confidentiality than a
handheld survey.
Most scales currently used in epilepsy focus on the disease and its
physical characteristics (e.g., the Liverpool Seizure Severity scale [18]),
on psychiatric aspects of the disease (e.g., the Neurological Disorder
Depression Inventory for Epilepsy (NDDI-E)) [19], or on adverse events
[20]. These questionnaires are currently used in clinical trials for drug
research, educational interventions, and assessment of the effect of
interventions (e.g., epilepsy surgery). Moreover, most questionnaires
used to evaluate general satisfaction focus on the hospitalization period.
However, patients with epilepsy usually need continuous outpatient
follow-up, requiring tools to assess perceptions of patients regarding
healthcare interventions, especiallywith respect to communication, satis-
faction with the professional relationship, and outpatient organization. In
this regard, validation of the Quality of Life scale in Epilepsy and its subse-
quent adaptations [21–23] was a turning point in the holistic assessment
of epilepsy care, showing that evaluation of the degree of satisfaction
perceived by patients may be crucial in improving care systems.The SEC questionnaire is the only scale currently able to assess satis-
faction with care in epilepsy [9] and is a valid approach to measure
patient satisfaction regarding specific aspects such as outpatient
follow-up. The original SEC version was culturally adapted to the
Spanish context, showing an adequate reliability and validity. The vali-
dation process used a translation-back-translation and validation of
contents by expert panels to adapt the original questionnaire to a
Mediterranean/Spanish cultural scenario. Thus, in order to adapt the
original German version to Spanish, we modified aspects related to
language expressions and cultural settings, which were reviewed
by the author of the original version to ensure consistency between
both questionnaires. Only one item of the original questionnaire
(e.g., “technique of blood taking”) had to be eliminated from the SEC-
E to be adapted to our healthcare system. This was probably due to
the fact that in our hospital, blood is usually drawn in an outpatient
lab and is not considered related to the epilepsy clinic. The internal
consistency and stability tests showed adequate reliability.
The SEC-E also showed high internal consistency, with a Cronbach's
α of 0.85, 0.89, and 0.93 for satisfaction with organization, communica-
tion, and assessment, respectively, values comparable to the internal
consistency obtained in the original SEC version (0.85, 0.92, and 0.95,
respectively) [9]. Moreover, the results of the reproducibility test
showed stability in the implementation of the tool over time, obtaining
a significant ICC2,1 in all the items evaluated.
In the original SEC [9], the German scale was correlated with other
scales assessing relevant aspects in epilepsy such as the Quality of Life
in Epilepsy (QUOLIE) and Hospital Anxiety and Depression scale
(HADs), showing adequate validity criteria [9]. Comparison of the SEC-
E with the SHP showed the three SEC-E domains directly correlated
with the SHP items with similar content.
We found a poor response to some satisfaction items regarding
counseling, which were related to differing patient needs, with some
participants reporting that counseling was not needed.
Quality of healthcare should be focused on individual needs.
In this regard, satisfaction and information provided to patients
have to be properly measured with adequate tools. Control of
seizures, number of antiepileptic drugs, in addition to stigma and
perception of disease, may have influenced the responses to the di-
mension of “satisfaction with information and counseling/advise”.
Moreover, in more independent and less affected patients, there is
no need to evaluate some aspects included in the questionnaire,
such as assessment of “career opportunities”, “problems at work or
at school”, or “social support/aid”. However, these differences did
not affect the final score because the answers “no need” were not
counted in the final result. Some other questions could be helpful
for most patients at any time of the disease such as “provision of
aids” or “social support”, and others like “dealing with the impact of
epilepsy on family and yourself” may be related to stigma, which is
a particularly useful component to incorporate when developing
interventions aimed at promoting social well-being in diverse
people with epilepsy [24].
6 I. Manzanares et al. / Epilepsy & Behavior 102 (2020) 106812The importance of less frequently answered questions about the in-
formation and advice dimension is justified by their relevance to the in-
troduction of programs and actions that aim to provide patients and
their families with greater knowledge on epilepsy, promote communi-
cation between health professionals and patients, and encourage the
participation of patients and their families during treatment [25].
“Driving and driver's license” is an important goal in epilepsy advice
[26]. However, a high percentage of patients believe that they do not
need this information because they have never driven because of their
seizures or they drive legally normally because of correct epilepsy con-
trol. Nevertheless, advice is appropriate in this regard. Patients need to
be aware of the implications of unexpected seizures with loss of con-
sciousness. However, if freedom from seizures allows them to drive,
this ability may minimize the stigma often perceived. In both cases,
this item of the information seems very important to guarantee both
patients' rights and ensure safe driving [26].
5. Study strengths and limitations
The participation of the questionnaire's original authors ensured
adequate study reliability as well as facilitating understanding of the
results and comparisons.
However, measuring patient satisfaction with care may be not
feasible, especially when different seizure etiologies, therapies, and
differing degrees of seizure control are considered. This limitation
is reflected in the results of the third part of the questionnaire
(satisfaction with information and assessment), in which a high
percentage of patients responded that they did not need any infor-
mation. Consequently, prospective studies are required to assess
sensitivity to change.
6. Conclusions
Our study confirms the validity and reliability of the SEC-E in
measuring satisfaction with care in patients with epilepsy, providing
an appropriate version of the scale for Spanish-speaking countries. The
SEC-E is a useful tool in clinical practice, supporting previous studies
with the original German SEC questionnaire. The SEC-E is indicated for
the assessment of specific aspects of educational interventions related
to epilepsy in our sociocultural context, such as satisfaction with
communication and organization, information and counseling, and the
relationship with health professionals. Specific tools such as the SEC-E
that evaluate patient aspects beyond their care are useful in empowering
patients by assessing the quality of evidence-based care within the
health system. Further studies will be needed in order to evaluate the
usefulness of the SEC-E for the assessment of interventional procedures
in epilepsy.
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